Boulder Ventures Iv Annex Lp - Net Worth and Insider Trading

Boulder Ventures Iv Annex Lp Net Worth

The estimated net worth of Boulder Ventures Iv Annex Lp is at least $102 dollars as of 2024-11-13. Boulder Ventures Iv Annex Lp is the 10% Owner of ARCA biopharma Inc and owns about 4 shares of ARCA biopharma Inc (ABIO) stock worth over $102. Details can be seen in Boulder Ventures Iv Annex Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boulder Ventures Iv Annex Lp has not made any transactions after 2009-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Boulder Ventures Iv Annex Lp

Boulder Ventures Iv Annex Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Boulder Ventures Iv Annex Lp owns 1 companies in total, including ARCA biopharma Inc (ABIO) .

Click here to see the complete history of Boulder Ventures Iv Annex Lp’s form 4 insider trades.

Insider Ownership Summary of Boulder Ventures Iv Annex Lp

Ticker	Comapny	Transaction Date	Type of Owner
ABIO	ARCA biopharma Inc	2009-01-27	10 percent owner

Boulder Ventures Iv Annex Lp Latest Holdings Summary

Boulder Ventures Iv Annex Lp currently owns a total of 1 stock. Boulder Ventures Iv Annex Lp owns 4 shares of ARCA biopharma Inc (ABIO) as of January 27, 2009, with a value of $102.

Latest Holdings of Boulder Ventures Iv Annex Lp

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ABIO	ARCA biopharma Inc	2009-01-27	4	25.50	102

Holding Weightings of Boulder Ventures Iv Annex Lp

Boulder Ventures Iv Annex Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Boulder Ventures Iv Annex Lp has made a total of 0 transactions in ARCA biopharma Inc (ABIO) over the past 5 years. The most-recent trade in ARCA biopharma Inc is the sale of 0 shares on January 27, 2009, which brought Boulder Ventures Iv Annex Lp around $0.

Insider Trading History of Boulder Ventures Iv Annex Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Boulder Ventures Iv Annex Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Boulder Ventures Iv Annex Lp Ownership Network

Ownership Network List of Boulder Ventures Iv Annex Lp

No Data

Ownership Network Relation of Boulder Ventures Iv Annex Lp

Boulder Ventures Iv Annex Lp Owned Company Details

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Boulder Ventures Iv Annex Lp is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Boulder Ventures Iv Annex Lp made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 485 shares, with a net purchase of 485 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

Boulder Ventures Iv Annex Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Boulder Ventures Iv Annex Lp. You might contact Boulder Ventures Iv Annex Lp via mailing address: 1900 Ninth Street, Suite 200, Boulder Co 80302.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.